Cargando…

Comparison of the Effect of Unfractionated Heparin and Enoxaparin Sodium at Different Doses on the Course of COVID-19-Associated Coagulopathy

Background: COVID-19-associated coagulopathy (CAC) exacerbates the course of coronavirus infection and contributes to increased mortality. Current recommendations for CAC treatment include the use of low-molecular weight heparins (LMWH) at prophylactic or therapeutic doses, as well as the use of unf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oliynyk, Oleksandr, Barg, Wojciech, Slifirczyk, Anna, Oliynyk, Yanina, Dubrov, Serhij, Gurianov, Vitaliy, Rorat, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8537389/ https://www.ncbi.nlm.nih.gov/pubmed/34685403 http://dx.doi.org/10.3390/life11101032

Ejemplares similares

Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants
por: Oliynyk, Oleksandr, et al.
Publicado: (2022)

Efficacy of Tocilizumab Therapy in Different Subtypes of COVID-19 Cytokine Storm Syndrome
por: Oliynyk, Oleksandr, et al.
Publicado: (2021)

Efficacy of Sildenafil in Patients with Severe COVID-19 and Pulmonary Arterial Hypertension
por: Oliynyk, Oleksandr Valentynovych, et al.
Publicado: (2023)

Impact of Alteplase on Mortality in Critically Ill Patients with COVID-19 and Pulmonary Embolism
por: Oliynyk, Oleksandr Valentynovych, et al.
Publicado: (2023)

Oxygen metabolism markers as predictors of mortality in severe COVID-19
por: Oliynyk, Oleksandr V., et al.
Publicado: (2021)

Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa
por: Lewis, Joseph, et al.
Publicado: (2022)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

Cost-utility of enoxaparin compared with unfractionated heparin in unstable coronary artery disease
por: Nicholson, Tricia, et al.
Publicado: (2001)

Assay-Based Differentiation in the Neutralization Profile of Unfractionated Heparin, Enoxaparin, and Fondaparinux by Andexanet Alfa
por: Siddiqui, Fakiha, et al.
Publicado: (2020)

Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients
por: Pawlowski, Colin, et al.
Publicado: (2021)

Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients
por: Samuel, Sophie, et al.
Publicado: (2023)

The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients
por: Pineo, Graham F, et al.
Publicado: (2012)

Unfractionated Heparin with Sequential Enoxaparin in Patients with Complex Coronary Artery Lesions during Percutaneous Coronary Intervention
por: Li, Zhi-Zhong, et al.
Publicado: (2018)

Standard dosing of enoxaparin versus unfractionated heparin in critically ill patient with COVID-19: a multicenter propensity-score matched study
por: Al Sulaiman, Khalid, et al.
Publicado: (2022)

Enoxaparin-sodium/heparin: Heparin-induced thrombocytopenia: case report
Publicado: (2021)

Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis
por: Silvain, Johanne, et al.
Publicado: (2012)

Low-Dose Unfractionated Heparin with Sequential Enoxaparin in Patients with Diabetes Mellitus and Complex Coronary Artery Disease during Elective Percutaneous Coronary Intervention
por: Huang, Ji, et al.
Publicado: (2018)

Unfractionated heparin and enoxaparin reduce high-stretch ventilation augmented lung injury: a prospective, controlled animal experiment
por: Li, Li-Fu, et al.
Publicado: (2009)

The effect of unfractionated heparin, enoxaparin, and danaparoid on lupus anticoagulant testing: Can activated carbon eliminate false‐positive results?
por: De Kesel, Pieter M.M., et al.
Publicado: (2019)

Enoxaparin sodium/heparin: Heparin-induced thrombocytopenia: 2 case reports
Publicado: (2021)

Enoxaparin sodium: Heparin-induced thrombocytopenia: case report
Publicado: (2021)

Enoxaparin-sodium/heparin: Lack-of-efficacy: case report
Publicado: (2022)

Enoxaparin sodium: Heparin-induced thrombocytopenia: case report
Publicado: (2021)

Enoxaparin versus Unfractionated Heparin for the Perioperative Anticoagulant Therapy in Patients with Mechanical Prosthetic Heart Valve Undergoing Non-Cardiac Surgery
por: Iliuta, Luminita, et al.
Publicado: (2022)

Enoxaparin-sodium/heparin: Heparin-induced thrombocytopenia and lack of efficacy: case report
Publicado: (2020)

Unfractionated and low molecular weight heparin
por: Lima, Marcelo, et al.
Publicado: (2014)

Individual variation in unfractionated heparin dosing after pediatric cardiac surgery
por: Hikino, Keiko, et al.
Publicado: (2020)

Aspirin/enoxaparin sodium/heparin: Bleeding: 3 case reports
Publicado: (2021)

Enoxaparin sodium/heparin/tenecteplase: Haematoma: 6 case reports
Publicado: (2022)

Aspirin/enoxaparin-sodium/heparin: Lack of efficacy: case report
Publicado: (2021)

Enoxaparin-sodium/heparin/warfarin: Heparin-induced thrombocytopenia and elevated INR: case report
Publicado: (2021)

Unfractionated heparin and mechanical thromboprophylaxis in hip arthroplasty
por: Garcia, Flávio Luís, et al.
Publicado: (2015)

A comparison of enoxaparin with unfractionated heparins in patients with coronary heart disease in an emergency department in rural South Indian tertiary care teaching hospital
por: Ahmad, Akram, et al.
Publicado: (2015)

Enoxaparin sodium/heparin/warfarin: Various toxicities: 3 case reports
Publicado: (2021)

Enoxaparin-sodium/heparin: Rectus sheath haematoma: 2 case reports
Publicado: (2021)

Pregnancy outcome in women with mechanical prosthetic heart valvesat their first trimester of pregnancy treated with unfractionated heparin (UFH) or enoxaparin: A randomized clinical trial
por: Movahedi, Minoo, et al.
Publicado: (2020)

Real-World Comparative Effectiveness and Cost Comparison of Thromboprophylactic Use of Enoxaparin versus Unfractionated Heparin in 376,858 Medically Ill Hospitalized US Patients
por: Veeranki, S. Phani, et al.
Publicado: (2020)

Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments
por: Davenport, Andrew
Publicado: (2012)

Impact of COVID-19 on monitoring of therapeutic unfractionated heparin
por: Adie, Sarah K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_edaob3deibfu93ksbivfg009op